Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation
Primary Purpose
Polycystic Ovarian Syndrome (PCOS), Insulin Resistance, Overweight
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Aerobic Exercise Training
Sponsored by
About this trial
This is an interventional basic science trial for Polycystic Ovarian Syndrome (PCOS) focused on measuring Polycystic Ovarian Syndrome (PCOS), Insulin Resistance, Overweight, Obese Women, Protein Metabolism, Post Translational Modifications
Eligibility Criteria
Inclusion Criteria:
- BMI between 25 kg/m2 and 40 kg/m2
- Fasting blood glucose < 126 mg/dL
- Diagnosed with PCOS as outlined by the Rotterdam criteria
- Insulin resistant as determined by a 3 hour oral glucose tolerance test
Exclusion Criteria:
- Serum creatinine ≥1.5 mg/ dL.
- Serum transaminase elevation ≥ 3 times the upper limit of normal range
- Use of systemic glucocorticoids
- Use of oral anticoagulation
- Pregnancy
Sites / Locations
- Mayo Clinic
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Sedentary Control
Aerobic Exercise Training
Arm Description
Participants will be randomized to an exercise training program or sedentary control group. The sedentary will not perform any structured physical activity or exercise. Participants will be encouraged to maintain their sedentary lifestyle and will be monitored by an accelerometer to track physical activity.
Participants will perform 12-weeks of aerobic exercise training
Outcomes
Primary Outcome Measures
Change in insulin sensitivity
To determine the effect of 12 weeks of aerobic exercise training or sedentary behavior on insulin sensitivity measured by a 3 hour hyperinsulinemic-euglycemic clamp and response to a mixed-meal.
Secondary Outcome Measures
Protein modifications and accumulation
Alterations in protein modifications and accumulation will be measured by a novel methodology developed within our laboratory. Infusion of stable amino acid isotopes will be used to measure the accumulation of proteins before and after 12 weeks of aerobic exercise training or sedentary behavior. Plasma and muscle will be resolved using a two dimensional gel electrophoresis which will allow the identification of protein modifications and age.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02105428
Brief Title
Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation
Official Title
Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation
Study Type
Interventional
2. Study Status
Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
July 2010 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
A goal of this study is to use a novel methodology to determine whether insulin resistance in women with polycystic ovary syndrome (PCOS) is related to the accumulation of proteins with modifications. This could lead to future research to determine if these modifications interfere with their proper function. Additionally, the investigators will determine how protein quality is affected by exercise training. Aerobic exercise enhances the endogenous oxidant buffering systems which may minimize oxidative damage to proteins. The investigators propose that aerobic exercise minimizes the accrual of modified proteins by increasing the synthesis of new proteins, but also by increasing the degradation and removal of old and damaged proteins. Based on our previous studies the investigators observed that insulin affects plasma protein synthesis and aerobic exercise improves insulin sensitivity not only in muscle but also in liver. The investigators therefore propose that aerobic exercise and related increase in insulin sensitivity (and decline in insulin levels) will reduce accumulation of old and modified skeletal muscle and plasma proteins leading to improved function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Polycystic Ovarian Syndrome (PCOS), Insulin Resistance, Overweight, Obese
Keywords
Polycystic Ovarian Syndrome (PCOS), Insulin Resistance, Overweight, Obese Women, Protein Metabolism, Post Translational Modifications
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
44 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sedentary Control
Arm Type
No Intervention
Arm Description
Participants will be randomized to an exercise training program or sedentary control group. The sedentary will not perform any structured physical activity or exercise. Participants will be encouraged to maintain their sedentary lifestyle and will be monitored by an accelerometer to track physical activity.
Arm Title
Aerobic Exercise Training
Arm Type
Experimental
Arm Description
Participants will perform 12-weeks of aerobic exercise training
Intervention Type
Behavioral
Intervention Name(s)
Aerobic Exercise Training
Intervention Description
A progressive increase in duration, frequency and intensity so the last 8 weeks of exercise are performed for 60 min, 5 days per week and at 80% of aerobic capacity. The duration includes a 5 minute warm up and 5 minute cool down. All exercise will be performed on a stationary bicycle (i.e., cycle ergometer).
Primary Outcome Measure Information:
Title
Change in insulin sensitivity
Description
To determine the effect of 12 weeks of aerobic exercise training or sedentary behavior on insulin sensitivity measured by a 3 hour hyperinsulinemic-euglycemic clamp and response to a mixed-meal.
Time Frame
Measured before and after 12 weeks
Secondary Outcome Measure Information:
Title
Protein modifications and accumulation
Description
Alterations in protein modifications and accumulation will be measured by a novel methodology developed within our laboratory. Infusion of stable amino acid isotopes will be used to measure the accumulation of proteins before and after 12 weeks of aerobic exercise training or sedentary behavior. Plasma and muscle will be resolved using a two dimensional gel electrophoresis which will allow the identification of protein modifications and age.
Time Frame
Before and after 12 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
BMI between 25 kg/m2 and 40 kg/m2
Fasting blood glucose < 126 mg/dL
Diagnosed with PCOS as outlined by the Rotterdam criteria
Insulin resistant as determined by a 3 hour oral glucose tolerance test
Exclusion Criteria:
Serum creatinine ≥1.5 mg/ dL.
Serum transaminase elevation ≥ 3 times the upper limit of normal range
Use of systemic glucocorticoids
Use of oral anticoagulation
Pregnancy
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation
We'll reach out to this number within 24 hrs